Albutrepenonacog alfa
DrugBank ID: DB13884
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| pseudo-von Willebrand disease | 0.9994 | DL |
| primary release disorder of platelets | 0.9994 | DL |
| Glanzmann thrombasthenia | 0.9992 | DL |
| Scott syndrome | 0.9963 | DL |
| bleeding diathesis due to a collagen receptor defect | 0.9928 | DL |
| hemorrhagic disorder due to a constitutional thrombocytopenia | 0.9926 | DL |
| hemophilia | 0.9900 | DL |
| acquired coagulation factor deficiency | 0.9858 | DL |
| thrombotic thrombocytopenic purpura | 0.9821 | DL |
| fetal and neonatal alloimmune thrombocytopenia | 0.9754 | DL |
| inherited thrombophilia | 0.9741 | DL |
| platelet-type bleeding disorder | 0.9699 | DL |
| flood factor deficiency | 0.9681 | DL |
| hereditary thrombocytosis with transverse limb defect | 0.9613 | DL |
| familial thrombomodulin anomalies | 0.9611 | DL |
| methylcobalamin deficiency type cblG | 0.9508 | DL |
| Ehlers-Danlos syndrome, fibronectinemic type | 0.9459 | DL |
| thrombocytopenic purpura | 0.9408 | DL |
| symptomatic form of hemophilia in female carriers | 0.9192 | DL |
| congenital factor V deficiency | 0.8782 | DL |
| hemorrhagic disorder due to a platelet anomaly | 0.8719 | DL |
| hemophilia A with vascular abnormality | 0.7794 | DL |
| congenital factor XIII deficiency | 0.7783 | DL |
| familial apolipoprotein C-II deficiency | 0.7781 | DL |
| immune-mediated necrotizing myopathy | 0.7649 | DL |
| antisynthetase syndrome | 0.7577 | DL |
| factor XI deficiency | 0.7552 | DL |
| focal myositis | 0.7463 | DL |
| inherited prekallikrein deficiency | 0.7393 | DL |
| idiopathic eosinophilic myositis | 0.7195 | DL |
| inflammatory myopathy with abundant macrophages | 0.7195 | DL |
| congenital factor XI deficiency | 0.7170 | DL |
| primary hyperoxaluria | 0.7141 | DL |
| Ledderhose disease | 0.7034 | DL |
| infantile digital fibromatosis | 0.6856 | DL |
| C1 inhibitor deficiency | 0.6741 | DL |
| factor XIII, A subunit, deficiency | 0.6685 | DL |
| Tatsumi factor deficiency | 0.6619 | DL |
| serpinopathy with toxic serpin polymerization | 0.6612 | DL |
| multiple sclerosis-ichthyosis-factor VIII deficiency syndrome | 0.6512 | DL |
| palmar fibromatosis | 0.6432 | DL |
| lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis | 0.6327 | DL |
| autosomal dominant macrothrombocytopenia | 0.6079 | DL |
| corneal degeneration, band-shaped spheroid | 0.6056 | DL |
| esophageal varices with bleeding | 0.6047 | DL |
| esophageal varices without bleeding | 0.6047 | DL |
| FADD-related immunodeficiency | 0.5976 | DL |
| hemoglobin C-beta-thalassemia syndrome | 0.5957 | DL |
| laryngo-onycho-cutaneous syndrome | 0.5917 | DL |
| Sjogren-Larsson-like ichthyosis without CNS or eye involvement | 0.5871 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.